Krystal Biotech KRYS Q1 2026 Earnings Strong Earnings Beat Amidst Modest Stock Decline ATAT Q1 2026 Earnings Strong EPS Beat of 25 Despite Stock Pullback VZ Q1 2026 Earnings EPS Beats Estimates by Nearly 4 as Wireless Business Holds Steady AIT Q1 2026 Earnings EPS Misses Estimates by a Narrow Margin Stock Edges Higher REAL Q1 2026 Earnings Narrowing Losses as Consignment Volumes Improve CAC Q1 2026 Earnings EPS Beats Estimates Amid Stable Operations